Skip to main content
OpenTrials
Completed

NCT Number: NCT07695441

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults

This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHA University

Seongnam-si, Gyeonggi-do, 13503, South Korea

About this study

This study investigated whether walking with a wearable hip exoskeleton could modulate postprandial glycemic and physiological responses in healthy adults. Using a randomized crossover design, each participant completed four experimental conditions in a controlled laboratory setting: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode.

Postprandial glucose responses were assessed after meal ingestion during each experimental trial. Physiological responses, including heart rate, perceived exertion, and energy expenditure, were also evaluated to compare the metabolic and perceptual demands of walking with and without the wearable hip exoskeleton. The study was designed as a proof-of-concept trial to examine whether wearable hip exoskeleton-assisted walking may influence postprandial glucose regulation in healthy adults.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adults aged 20 to 65 years.
  • Participants who were able to complete walking trials with and without the wearable hip exoskeleton.
  • Participants who provided written informed consent before participation.

Exclusion criteria

  • Participants with diagnosed metabolic, cardiovascular, neurological, or musculoskeletal disorders.
  • Participants with conditions that could affect walking ability or safe use of the wearable hip exoskeleton.
  • Participants taking medications known to affect glucose metabolism.
  • Participants who were unable to comply with the study procedures.

Treatment and study plan

Walking Without Bot-Fit

Behavioral

Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton during the postprandial period.

Bot-Fit Aqua Mode

Device

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.

Bot-Fit Boost Mode

Device

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.

Primary outcomes

  1. Incremental Area Under the Curve for Postprandial Glucose

    Time frame: Up to 120 minutes after meal ingestion during each experimental trial

    Incremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.

Secondary outcomes

  1. Peak Postprandial Glucose Concentration

    Time frame: Up to 120 minutes after meal ingestion during each experimental trial

    The peak glucose concentration observed during the postprandial measurement period was compared across experimental conditions.

  2. Heart Rate Response

    Time frame: From the start to the end of the 30-minute intervention or control period on each experimental trial day

    Heart rate was assessed during each experimental condition to evaluate physiological responses to walking with and without the wearable hip exoskeleton.

  3. Rating of Perceived Exertion

    Time frame: Immediately after each experimental condition

    Rating of perceived exertion was assessed to compare subjective exercise intensity across walking conditions.

Sponsors and collaborators

Lead sponsor

CHA University

Other

Collaborators

  • Samsung Electronics

Registry information

Official study title

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults: A Randomized Crossover Proof-of-Concept Study

Acronym: Bot-Fit Health

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 10, 2026
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.